506 related articles for article (PubMed ID: 19696696)
1. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
Vegter S; Perna A; Hiddema W; Ruggenenti P; Remuzzi G; Navis G; Postma MJ
Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor.
Costa-Scharplatz M; van Asselt AD; Bachmann LM; Kessels AG; Severens JL
Pharmacogenet Genomics; 2007 May; 17(5):359-68. PubMed ID: 17429318
[TBL] [Abstract][Full Text] [Related]
3. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.
Clark WF; Churchill DN; Forwell L; Macdonald G; Foster S
CMAJ; 2000 Jan; 162(2):195-8. PubMed ID: 10674051
[TBL] [Abstract][Full Text] [Related]
4. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
van der Kleij FG; Schmidt A; Navis GJ; Haas M; Yilmaz N; de Jong PE; Mayer G; de Zeeuw D
Kidney Int Suppl; 1997 Dec; 63():S23-6. PubMed ID: 9407415
[TBL] [Abstract][Full Text] [Related]
6. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
[TBL] [Abstract][Full Text] [Related]
7. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
[TBL] [Abstract][Full Text] [Related]
8. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
9. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
[TBL] [Abstract][Full Text] [Related]
10. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis.
Woo KT; Lau YK; Zhao Y; Liu FE; Tan HB; Tan EK; Stephanie FC; Chan CM; Wong KS
Cell Mol Immunol; 2007 Jun; 4(3):227-32. PubMed ID: 17601378
[TBL] [Abstract][Full Text] [Related]
11. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
12. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
[TBL] [Abstract][Full Text] [Related]
13. [Association between ACE gene polymorphism and therapeutic responsiveness of ACEI in diabetic nephropathy].
Wang L; Pan CY; Hu W
Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):372-4. PubMed ID: 10923445
[TBL] [Abstract][Full Text] [Related]
14. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of sevelamer in patients with end-stage renal disease.
Manns B; Klarenbach S; Lee H; Culleton B; Shrive F; Tonelli M
Nephrol Dial Transplant; 2007 Oct; 22(10):2867-78. PubMed ID: 17595182
[TBL] [Abstract][Full Text] [Related]
17. [A prospective study on the cough mechanism induced by angiotensin-converting enzyme inhibitors in patients with hypertension].
Ye RJ; He QY; Gai J; Shang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):581-4. PubMed ID: 15498266
[TBL] [Abstract][Full Text] [Related]
18. [The significance of angiotensin-converting enzyme inhibitors genotype for ACEi response in patients with chronic allograft nephropathy].
Savin M; Petronić V
Srp Arh Celok Lek; 2005; 133(3-4):194-8. PubMed ID: 16206711
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
[TBL] [Abstract][Full Text] [Related]
20. ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1.
Perna A; Ruggenenti P; Testa A; Spoto B; Benini R; Misefari V; Remuzzi G; Zoccali C
Kidney Int; 2000 Jan; 57(1):274-81. PubMed ID: 10620209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
